GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

ScinoPharm Taiwan 1789.TW · TWD

Health Care · Taiwan Stock Exchange · 🇹🇼 Taiwan

Compare

20.85

+3.47%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Popular Bitcoin Ethereum Nvidia Apple S&P 500 Gold EUR/USD US 10Y

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 3.16bn

FY2016FY2025

Net income

TWD 137.0m

FY2016FY2025

Free cash flow

TWD 305.8m

FY2016FY2025

Shareholders' equity

TWD 10.52bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueTWD 3.16bnTWD 3.41bnTWD 3.19bnTWD 3.26bnTWD 2.76bnTWD 3.08bnTWD 2.89bnTWD 3.52bnTWD 3.52bnTWD 4.03bn
Gross profitTWD 1.10bnTWD 1.30bnTWD 1.22bnTWD 1.25bnTWD 1.28bnTWD 1.32bnTWD 1.18bnTWD 1.54bnTWD 1.55bnTWD 1.81bn
Research and developmentTWD 497.3mTWD 459.4mTWD 357.7mTWD 271.3mTWD 306.0mTWD 245.6mTWD 238.4mTWD 313.2mTWD 314.3mTWD 279.6m
Operating incomeTWD 108.9mTWD 322.7mTWD 314.5mTWD 405.6mTWD 288.7mTWD 375.5mTWD 267.1mTWD 558.3mTWD 559.0mTWD 868.3m
Net incomeTWD 137.0mTWD 339.4mTWD 287.1mTWD 353.2mTWD 243.5mTWD 282.1mTWD 216.7mTWD 443.0mTWD 422.4mTWD 658.7m
Diluted earnings per share0.160.430.360.440.310.360.270.560.470.83

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsTWD 11.86bnTWD 11.94bnTWD 11.72bnTWD 11.91bnTWD 11.69bnTWD 11.85bnTWD 11.67bnTWD 12.56bnTWD 12.70bnTWD 12.78bn
Cash and short-term investmentsTWD 3.11bnTWD 4.17bnTWD 3.95bnTWD 4.35bnTWD 4.13bnTWD 4.09bnTWD 3.48bnTWD 4.38bnTWD 3.91bnTWD 3.71bn
Total liabilitiesTWD 1.33bnTWD 1.42bnTWD 1.36bnTWD 1.46bnTWD 1.18bnTWD 1.32bnTWD 1.41bnTWD 2.02bnTWD 2.28bnTWD 2.56bn
DebtTWD 153.9mTWD 675.5mTWD 619.9mTWD 676.7mTWD 558.2mTWD 576.2mTWD 840.0mTWD 1.41bnTWD 1.69bnTWD 1.79bn
Shareholders' equityTWD 10.52bnTWD 10.53bnTWD 10.36bnTWD 10.45bnTWD 10.51bnTWD 10.53bnTWD 10.26bnTWD 10.54bnTWD 10.42bnTWD 10.23bn
Shares outstanding842m795m794m794m793m792m791m791m904m796m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsTWD 597.1mTWD 750.9mTWD 231.1mTWD 773.8mTWD 509.8mTWD 946.3mTWD 788.9mTWD 1.23bnTWD 971.7mTWD 1.67bn
Capital spending−TWD 291.3m−TWD 288.7m−TWD 284.7m−TWD 250.0m−TWD 321.3m−TWD 183.1m−TWD 105.7m−TWD 127.0m−TWD 410.9m−TWD 458.5m
Free cash flowTWD 305.8mTWD 462.2m−TWD 53.6mTWD 523.7mTWD 188.5mTWD 763.2mTWD 683.2mTWD 1.10bnTWD 560.8mTWD 1.21bn
Dividends paid−TWD 276.8m−TWD 237.2m−TWD 284.7m−TWD 379.6m−TWD 395.4m−TWD 213.5m−TWD 387.5m−TWD 379.6m−TWD 228.1m−TWD 219.3m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueTWD 678.5mTWD 659.7mTWD 1.01bnTWD 721.5mTWD 747.5mTWD 686.4mTWD 1.04bnTWD 724.2m
Gross profitTWD 134.6mTWD 221.5mTWD 333.1mTWD 188.1mTWD 319.5mTWD 228.0mTWD 377.1mTWD 279.0m
Operating income−TWD 65.4mTWD 8.5mTWD 8.0m−TWD 19.6mTWD 80.3mTWD 38.4mTWD 66.2mTWD 31.8m
Net income−TWD 35.5mTWD 16.5mTWD 41.3mTWD 15.4mTWD 34.2mTWD 46.0mTWD 97.3mTWD 27.1m
Diluted earnings per share-0.040.020.050.020.040.050.120.03
Cash from operationsTWD 237.0mTWD 199.0mTWD 343.0mTWD 25.0mTWD 50.0mTWD 176.0mTWD 254.0mTWD 74.0m
Capital spending−TWD 17.0m−TWD 83.0m−TWD 82.0m−TWD 45.0m−TWD 61.0m−TWD 104.0m−TWD 48.0m−TWD 105.0m
Free cash flowTWD 220.0mTWD 116.0mTWD 261.0m−TWD 20.0m−TWD 11.0mTWD 72.0mTWD 206.0m−TWD 31.0m
Total assetsTWD 12.36bnTWD 11.86bnTWD 11.86bnTWD 12.31bnTWD 11.96bnTWD 12.06bnTWD 11.94bnTWD 11.78bn
Cash and short-term investmentsTWD 3.50bnTWD 3.27bnTWD 3.11bnTWD 2.85bnTWD 3.09bnTWD 3.10bnTWD 4.17bnTWD 3.98bn
DebtTWD 208.7mTWD 194.8mTWD 153.9mTWD 163.3mTWD 106.6mTWD 76.1mTWD 56.4mTWD 55.6m
Shareholders' equityTWD 10.46bnTWD 10.31bnTWD 10.52bnTWD 10.99bnTWD 10.27bnTWD 10.69bnTWD 10.53bnTWD 10.44bn

Financial ratios

Data as of 29 Sept 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin34.7%38.2%38.2%38.3%46.4%42.7%
Operating margin3.4%9.5%9.9%12.4%10.5%12.2%
Net margin4.3%10.0%9.0%10.8%8.8%9.1%
Return on equity1.3%3.2%2.8%3.4%2.3%2.7%
Return on assets1.2%2.8%2.4%3.0%2.1%2.4%
Free cash flow yield5.7%7.1%3.5%7.0%5.7%7.7%
Revenue growth-7.1%6.9%-2.4%18.2%-10.4%6.6%
Earnings growth-59.6%18.2%-18.7%45.1%-13.7%30.2%
Current ratio7.74x8.61x8.75x7.87x10.73x8.62x
Debt to equity0.01x0.01x0.00x0.01x0.00x0.00x
Equity ratio88.8%88.1%88.4%87.7%89.9%88.9%
Interest coverage11.04x39.92x34.38x51.26x44.10x24.76x
R&D as a share of sales15.7%13.5%11.2%8.3%11.1%8.0%
Buybacks as a share of market value-6.0%-0.0%-0.1%-0.1%-0.1%-0.2%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-1.0%0.5%-2.2%
Operating income-35.5%-21.9%-17.5%
Net income-27.1%-13.5%-14.2%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin36.5%37.4%39.6%41.4%
Operating margin6.6%8.8%9.6%13.1%
Net margin7.2%8.6%8.7%10.9%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings103.051.673.057.280.381.097.143.175.844.9
Price to sales4.55.16.66.27.17.47.35.49.17.3

Dividends and splits

Per share, in the currency the company pays

Paid for 15 years. Last went ex-dividend on 2 Jul 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year0.290.350.300.360.480.500.270.49
  • 1.04-for-1 split · 10 Aug 2017
  • 1.04-for-1 split · 10 Aug 2016
  • 1.04-for-1 split · 6 Aug 2015
  • 1.04-for-1 split · 7 Aug 2014
  • 1.04-for-1 split · 8 Aug 2013
  • 1.03-for-1 split · 9 Aug 2012

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.